Albulym Obaid M, Kennerson Marina L, Harms Matthew B, Drew Alexander P, Siddell Anna H, Auer-Grumbach Michaela, Pestronk Alan, Connolly Anne, Baloh Robert H, Zuchner Stephan, Reddel Stephen W, Nicholson Garth A
Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, NSW, Australia.
Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Ann Neurol. 2016 Mar;79(3):419-27. doi: 10.1002/ana.24575. Epub 2016 Jan 13.
To use linkage analysis and whole exome sequencing to identify the genetic mutation in a multigenerational Australian family with Charcot-Marie-Tooth disease type 2 (CMT2) and pyramidal signs.
Genome-wide linkage analysis was performed to map the locus. Whole exome sequencing was undertaken on selected individuals (3 affected, 1 normal), and segregation analysis and mutation screening were carried out using high-resolution melt analysis. The GEM.app database was queried to identify additional families with mutations.
Significant linkage (2-point LOD score ≥ +3) and haplotype analysis mapped a new locus for CMT2 and pyramidal signs to a 6.6Mb interval on chromosome 22q12.1-q12.3. Whole exome sequencing identified a novel mutation (p.R252W) in the microrchidia CW-type zinc finger 2 (MORC2) gene mapping within the linkage region. The mutation fully segregated with the disease phenotype in the family. Screening additional families and querying unsolved CMT2 exomes, we identified the p.R252W mutation in 2 unrelated early onset CMT2 families and a second mutation p.E236G in 2 unrelated CMT2 families. Both the mutations occurred at highly conserved amino acid residues and were absent in the normal population.
We have identified a new locus in which MORC2 mutations are the likely pathogenic cause of CMT2 and pyramidal signs in these families. MORC2 encodes the human CW-type zinc finger 2 protein, which is a chromatin modifier involved in the regulation of DNA repair as well as gene transcription.
运用连锁分析和全外显子组测序,在一个患有2型腓骨肌萎缩症(CMT2)并伴有锥体束征的澳大利亚多代家族中鉴定基因突变。
进行全基因组连锁分析以定位基因座。对选定个体(3名患者、1名正常人)进行全外显子组测序,并使用高分辨率熔解分析进行分离分析和突变筛查。查询GEM.app数据库以识别其他有突变的家族。
显著连锁(两点LOD评分≥+3)和单倍型分析将CMT2和锥体束征的一个新基因座定位到22号染色体q12.1-q12.3区域的一个6.6Mb区间。全外显子组测序在连锁区域内的小睾丸CW型锌指蛋白2(MORC2)基因中鉴定出一个新突变(p.R252W)。该突变在家族中与疾病表型完全共分离。筛查其他家族并查询未解决的CMT2外显子组,我们在2个无关的早发性CMT2家族中鉴定出p.R252W突变,在2个无关的CMT2家族中鉴定出第二个突变p.E236G。这两个突变均发生在高度保守的氨基酸残基处,且在正常人群中不存在。
我们已经鉴定出一个新基因座,其中MORC2突变可能是这些家族中CMT2和锥体束征的致病原因。MORC2编码人类CW型锌指蛋白2,它是一种染色质修饰因子,参与DNA修复以及基因转录的调控。